Paracetamol and metabolite pharmacokinetics in infants
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Background Data concerning metabolism of paracetamol in infants are scant. Previous studies have examined urinary metabolite recovery rates after a single dose of paracetamol in either neonates ( Methods Infants ( n=47) undergoing major craniofacial surgery were given paracetamol 19-45 mg/kg 6-, 8-, or 12-hourly as either elixir or suppository formulation for postoperative analgesia, after a loading dose of 33-59 mg/kg rectally during the operation. Serum was assayed for paracetamol concentration in 40 of these infants at 5, 8, 11, 14, 17 and 20 h postoperatively. Urine samples were collected every 3 h for 24 h in 15 of these infants. The clearances of paracetamol to glucuronide and sulphate metabolites as well as the urinary clearance of unmetabolised paracetamol were estimated using non-linear, mixed-effects models. Results Mean (+/-SD) age and weight of the patients were 11.8+/-2.5 months and 9.1+/-1.9 kg. Clearances of paracetamol to paracetamol-glucuronide (%CV) and to paracetamol-sulphate were 6.6 (11.5) l/h and 7.5 (11.5) l/h respectively, standardised to a 70-kg person using allometric "1/4 power" models. Glucuronide formation clearance, but not sulphate formation, was related to age and increased with age from a predicted value in a neonate of 2.73 l/h/70 kg to a mature value of 6.6 l/h/70 kg with a maturation half-life of 8.09 months. Urine clearance of paracetamol-glucuronide, paracetamol-sulphate and unchanged paracetamol (%CV) were, respectively, 2.65, 3.03 and 0…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“One study analysed the urinary excretion of the two conjugates (0-36 h) and found that the ratio of paracetamol-glucuronide to paracetamol-sulfate for neonates (1-2 days old), children (3-9 years) and older children (12 years old) was 0.34, 0.75 and 1.61, respectively, with an adult ratio of 1.80 (see figure 1).6”
From Paracetamol: pharmacology, prescribing and controversies (2016) · cites this paper as [6]
Citations
Cites
A General Model for the Origin of Allometric Scaling Laws in Biology
West, G. B., Brown, J. H., & Enquist, B. J. (1997) · Science · doi:10.1126/science.276.5309.122 · Cited by 5,016 · cited 1×
“75 for clearance and 1 for distribution volumes [12, 13, 14, 15, 16].”
BackgroundThe Fourth Dimension of Life: Fractal Geometry and Allometric Scaling of Organisms
West, G. B., Brown, J. H., & Enquist, B. J. (1999) · Science · doi:10.1126/science.284.5420.1677 · Cited by 1,718 · cited 1×
“75 for clearance and 1 for distribution volumes [12, 13, 14, 15, 16].”
BackgroundA Size Standard for Pharmacokinetics
Holford, N. H. G. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199630050-00001 · Cited by 482 · cited 1×
“The parameter values were standardised for a body weight of 70 kg using an allometric model [11].”
MethodSelf-citationGlucuronidation in Humans: Pharmacogenetic and Developmental Aspects
de Wildt, S. N., Kearns, G. L., Leeder, J. S., & van den Anker, J. N. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199936060-00005 · Cited by 393 · cited 1×
“Enzyme activity is not only determined by postnatal age, but might also be regulated by both ontogenic and genetic processes, and these have not yet been elucidated [22].”
BackgroundContribution of CYP2E1 and CYP3A to acetaminophen reactive metabolite formation
MANYIKE, P., KHARASCH, E., KALHORN, T., & SLATTERY, J. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.104736 · Cited by 355
Acetaminophen elimination kinetics in neonates, children, and adults
Miller, R. P., Roberts, R. J., & Fischer, L. J. (1976) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1976193284 · Cited by 315
Anderson, B. J., van Lingen, R. A., Hansen, T. G., Lin, Y.-C., & Holford, N. H. G. (2002) · Anesthesiology · doi:10.1097/00000542-200206000-00012 · Cited by 240 · cited 2×
“8 l/h/70 kg at the age of 60 weeks post-conception [5].”
BackgroundSelf-citationSize, Myths and the Clinical Pharmacokinetics of Analgesia in Paediatric Patients
Anderson, B. J., McKee, A. D., & Holford, N. H. G. (1997) · Clinical Pharmacokinetics · doi:10.2165/00003088-199733050-00001 · Cited by 210 · cited 1×
“The increase relative to adults may be an artefact of a non-biological based size model and has been observed when applied to clearance [21].”
BackgroundSelf-citationWest, J. R., Smith, H. W., & Chasis, H. (1948) · The Journal of Pediatrics · doi:10.1016/s0022-3476(48)80124-1 · Cited by 205 · cited 1×
“There was no effect of age on unchanged APAP clearance because glomerular filtration rate and renal blood flow, corrected for body size, are mature by 6 months of age [25].”
BackgroundAnderson, B. J., Woollard, G. A., & Holford, N. H. G. (2000) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2000.00231.x · Cited by 194 · cited 5×
“Final parameter estimates with covariate analyses are shown in Table 1 and Table 2. Pharmacokinetic estimates and maturational half-lives of VP/F and CLT/F were similar to those reported previously [ 10 ].”
MethodResultInfluentialSelf-citationLevy, G., Khanna, N. N., Soda, D. M., Tsuzuki, O., & Stern, L. (1975) · Pediatrics · doi:10.1542/peds.55.6.818 · Cited by 187
A Survey of the Use of Off-Label and Unlicensed Drugs in a Dutch Children's Hospital
't Jong, G. W., Vulto, A. G., de Hoog, M., Schimmel, K. J. M., Tibboel, D., & van den Anker, J. N. (2001) · Pediatrics · doi:10.1542/peds.108.5.1089 · Cited by 166 · cited 1×
“The five most commonly prescribed drugs in our Paediatric Surgical Intensive Care Unit (PSICU) are nystatin, cisapride, APAP, cefotaxime and furosemide [1].”
BackgroundSelf-citationThe Association of Age and Frailty with Paracetamol Conjugation in Man
WYNNE, H. A., COPE, L. H., HERD, B., RAWLINS, M. D., JAMES, O. F. W., & WOODHOUSE, K. W. (1990) · Age and Ageing · doi:10.1093/ageing/19.6.419 · Cited by 149
van Lingen, R. A., Deinum, J. T., Quak, J. M. E., Kuizenga, A. J., van Dam, J. G., Anand, K. J. S., Tibboel, D., & Okken, A. (1999) · Archives of Disease in Childhood - Fetal and Neonatal Edition · doi:10.1136/fn.80.1.f59 · Cited by 147 · cited 4×
“[17] reported a glucuronide/sulphate ratio in urine of”
BackgroundInfluentialSelf-citationThe genotoxicity and carcinogenicity of paracetamol: a regulatory (re) view
Bergman, K., Müller, L., & Teigen, S. W. (1996) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/0027-5107(95)00185-9 · Cited by 132 · cited 8×
“The lack of urinary metabolites derived from NAPQI formation may mean that NAPQI formation is negligible in infants and thus explains the apparent lack of APAP hepatotoxicity in this age group.”
BackgroundInfluentialPRESCOTT, L. F., & WRIGHT, N. (1973) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1973.tb08536.x · Cited by 115
Scaling of blood parameters in mammals
Prothero, J. W. (1980) · Comparative Biochemistry and Physiology Part A Physiology · doi:10.1016/0300-9629(80)90255-8 · Cited by 97 · cited 1×
“75 for clearance and 1 for distribution volumes [12, 13, 14, 15, 16].”
BackgroundMiners, J. O., Attwood, J., & Birkett, D. J. (1984) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1984.64 · Cited by 90
Age-related differences in salicylamide and acetaminophen conjugation in man
Alam, S. N., Roberts, R. J., & Fischer, L. J. (1977) · The Journal of Pediatrics · doi:10.1016/s0022-3476(77)80787-7 · Cited by 90
Paracetamol metabolism in pregnancy.
Miners, J. O., Robson, R., & Birkett, D. (1986) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1986.tb02901.x · Cited by 82
Analgesic efficacy of rectal versus oral acetaminophen in children after major craniofacial surgery
van der Marel, C. D., van Lingen, R. A., Pluim, M. A. L., Scoones, G., van Dijk, M., Vaandrager, J. M., & Tibboel, D. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.116794 · Cited by 73
Self-citationComparison of paracetamol metabolism in young adult and elderly males
Miners, J. O., Penhall, R. K., Robson, R., & Birkett, D. J. (1988) · European Journal of Clinical Pharmacology · doi:10.1007/bf00609245 · Cited by 71
Drug use in the neonate: interrelationships of pharmacokinetics, toxicity, and biochemical maturity.
Warner, A. M. (1986) · Clinical Chemistry · doi:10.1093/clinchem/32.5.721 · Cited by 66 · cited 1×
“There is a relatively low level of activity of the cytochrome P450 CYP2E1 enzyme system [27, 28] in infants and this may contribute to the wider margin of safety reported in infants.”
BackgroundMitchell, M. C., Schenker, S., & Speeg, K. V. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111223 · Cited by 65
Paracetamol metabolites in the neonate following maternal overdose.
Roberts, I., Mj, R., Zulf Mughal, M., Ratcliffe, J. G., & Prescott, L. (1984) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1984.tb02453.x · Cited by 65 · cited 1×
“6% of drug excreted in children with chronic liver disease, there are no data available concerning these urinary metabolites in either healthy or sick infants, except for neonates after maternal overdose [30].”
BackgroundEffects of oral contraceptive steroids on acetaminophen metabolism and elimination
Mitchell, M. C., Hanew, T., Meredith, C. G., & Schenker, S. (1983) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1983.127 · Cited by 64
Al-Obaidy, S. S., Po, A. L. W., McKiernan, P. J., Glasgow, J. F. T., & Millership, J. S. (1995) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/0731-7085(95)01303-3 · Cited by 50 · cited 1×
“[29] reported that these metabolites contribute 12.”
Pharmacokinetics of acetaminophen elimination by anephric patients.
Lowenthal, D. T., Oie, S., Stone, J. C. V., Briggs, W. A., & Levy, G. (1976) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30450-7 · Cited by 49
Acetaminophen Poisoning in Infancy
Greene, J. W. (1983) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1983.02140300064018 · Cited by 44
Series: ‘Current issues in mutagenesis and carcinogenesis’
Romagna, F. (1988) · Mutation Research/Genetic Toxicology · doi:10.1016/0165-1218(88)90115-2 · Cited by 41
Rumble, R. H., Roberts, M. S., & Denton, M. J. (1991) · Clinical Pharmacokinetics · doi:10.2165/00003088-199120020-00007 · Cited by 36
Circadian rhythm of serum sulfate levels in man and acetaminophen pharmacokinetics
Hoffman, D., Wallace, S. M., & Verbeeck, R. K. (1990) · European Journal of Clinical Pharmacology · doi:10.1007/bf00280048 · Cited by 31
Physiological correlates of size
Peters, R. H. (1983) · Cambridge University Press eBooks · doi:10.1017/cbo9780511608551.005 · Cited by 30 · cited 1×
“75 for clearance and 1 for distribution volumes [12, 13, 14, 15, 16].”
BackgroundThe effect of propranolol on paracetamol metabolism in man.
Baraka, O., Truman, C. A., Ford, J., & Roberts, C. J. (1990) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1990.tb03631.x · Cited by 21
Therapeutic doses of codeine have no effect on acetaminophen clearance or metabolism
Sonne, J., Poulsen, H. E., Loft, S. H., D�ssing, M., Vollmer-Larsen, A., Simonsen, K., Thyssen, H. H., & Lundstr�m, K. (1988) · European Journal of Clinical Pharmacology · doi:10.1007/bf00555519 · Cited by 19
Paracetamol elimination in patients with non‐insulin dependent diabetes mellitus.
Kamali, F., Thomas, S., & Ferner, R. E. (1993) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1993.tb05672.x · Cited by 13
Paracetamol disposition in Thai patients during and after treatment of falciparum malaria
Ismail, S., Back, D. J., Edwards, G., Bangchang, K. N., & Karbwang, J. (1995) · European Journal of Clinical Pharmacology · doi:10.1007/bf00202175 · Cited by 13
Perturbation of paracetamol urinary metabolic ratios by urine flow rate.
Miners, J. O., Osborne, N., Tonkin, A., & Birkett, D. (1992) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1992.tb05643.x · Cited by 13
Paracetamol metabolism in patients with ulcerative colitis
Haderslev, Sonne, Poulsen, H. E., & Loft, S. H. (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00808.x · Cited by 12
Barraclough, M. A. (1972) · Clinical Science · doi:10.1042/cs0430709 · Cited by 10 · cited 1×
“APAP is passively reabsorbed throughout the entire nephron, and clearance is expected to increase with increasing urine flow [24].”
BackgroundParacetamolvergiftung im Säuglingsalter
Claaß, A., Gaude, M., & Schröder, H. (2008) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-2008-1059402 · Cited by 5 · cited 1×
“There is a relatively low level of activity of the cytochrome P450 CYP2E1 enzyme system [27, 28] in infants and this may contribute to the wider margin of safety reported in infants.”
Background
Cited by
The Transfer of Drugs and Therapeutics Into Human Breast Milk: An Update on Selected Topics
Sachs, H. C., COMMITTEE ON DRUGS, Frattarelli, D. A. C., Galinkin, J. L., Green, T. P., Johnson, T., Neville, K., Paul, I. M., & Van den Anker, J. (2013) · Pediatrics · doi:10.1542/peds.2013-1985 · Cited by 555
Mechanistic Basis of Using Body Size and Maturation to Predict Clearance in Humans
Anderson, B. J., & Holford, N. H. G. (2009) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.24.25 · Cited by 494
Self-citationLarson, A. M. (2007) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.06.006 · Cited by 451
Bartelink, I. H., Rademaker, C. M. A., Schobben, A. F. A. M., & van den Anker, J. N. (2006) · Clinical Pharmacokinetics · doi:10.2165/00003088-200645110-00003 · Cited by 418
“[16,43,64] These substrates are mainly glucuronipathways and renal excretion.”
BackgroundDevelopmental Pharmacokinetics in Pediatric Populations
Lu, H., & Rosenbaum, S. (2014) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/1551-6776-19.4.262 · Cited by 358
Metadata
- Authors
- van der Marel, C. D., Anderson, B. J., van Lingen, R. A., Holford, N. H. G., Pluim, M. A. L., Jansman, F. G. A., van den Anker, J. N., & Tibboel, D.
- Affiliations
- Maastricht University Medical Centre (NL)
- University of Auckland (NZ)
- Erasmus MC (NL)
- Isala (NL)
- Corresponding author
- Tibboel, Dick
- Venue
- European Journal of Clinical Pharmacology
- Published
- 2003-05-22
- Volume
- 59
- Issue
- 3
- Pages
- 243-251
- ISSN
- 0031-6970 (ISSN-L)
- 1432-1041
- OpenAlex
- W1999869154
- Cited by
- 98
- References
- 41
- Citations by year
- 2025: 4 · 2024: 5 · 2023: 2 · 2022: 1 · 2021: 6 · 2020: 2 · 2019: 5 · 2018: 4 · 2017: 4 · 2016: 3 · 2015: 1 · 2014: 8 · 2013: 5 · 2012: 3
- FWCI
- 5.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- European Journal of Clinical Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Sedative Agents
- Keywords
- paracetamol, pharmacokinetics, infants, paracetamol glucuronide, glucuronidation, sulfation, urinary clearance, postoperative analgesia, craniofacial surgery, allometric scaling, age-related clearance, neonates, children, suppository formulation
- MeSH terms
- Acetaminophen, Female, Humans, Infant, Male, Metabolic Clearance Rate, Pain, Postoperative, Postoperative Pain, Analgesics, Non-Narcotic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.